37.5% of class 3 obesity entrants exited clinical obesity entirely Waist circumference reduction: -24.1 cm at 12 mg vs -3.6 cm placebo 104 wk extension (n=532, BMI 35 baseline 121.7 kg, BMI 42.8): 12 mg to MTD: -30.3% (-85.0 lbs) 9 mg to MTD: -29.5% (-80.7 lbs) 4 mg to MTD: -27.9% (-73.3 lbs) Placebo to MTD: -19.2% (-49.9 lbs) Cardiometabolic improvements vs placebo: waist circumference, non-HDL cholesterol, triglycerides, systolic BP, hsCRP 4 mg dose: AE-driven discontinuation rate lower than placebo Strategic takeaways: First triple agonist past phase 3, ahead of every competing program TWL distribution closes gap with bariatric surgery (Roux-en-Y ~30%, sleeve ~25%) Pressure on bariatric procedure volumes, PBM utilization management regimes, ICER cost-effectiveness models LLY widens lead over NVO further
This delayed absorption, combined with the medications' known side effects, may increase the likelihood of nausea, vomiting, or abdominal discomfort
From glutathione IV drips to glutathione tablets , theres a range of treatments available to suit various needs and budgets
Add a Prebiotic or Probiotic Your gut bacteria may be out of balance due to changes in medication and digestion
My recommendations: Eat 1.3 - 1.6g of protein per kilogram of ideal body weight daily Resistance train 23x per week Use high-quality whey protein (like in my menopause power shake) Track progress with DEXA or smart scales like the InBody Dial H30 Its Not Willpower
Our highest-strength Retatrutide vial and the lowest cost-per-milligram option available